Exudative AMD with macular neovascularization (MNV) causes severe visual impairment and intravitreal injection of anti-vascular endothelial growth factor (VEGF) inhibitors or photodynamic therapy (PDT) are approved treatments for exudative AMD [3–8]. This evidence concerns the gene VEGFA and age-related macular degeneration.